...
首页> 外文期刊>Thoracic cancer. >Diagnostic utility of endobronchial ultrasound guided transbronchial needle aspiration for mediastinal lesions: A prospective three year, single centre analysis
【24h】

Diagnostic utility of endobronchial ultrasound guided transbronchial needle aspiration for mediastinal lesions: A prospective three year, single centre analysis

机译:支气管内超声引导下经支气管针吸对纵隔病变的诊断价值:前瞻性三年,单中心分析

获取原文
           

摘要

Background: The diagnostic yield of endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) over a 3-year period was analyzed.Methods: Consecutive patients who underwent EBUS for the evaluation of pulmonary/mediastinal lesions were recruited.Results: One hundred and ninety-one patients were studied (54% male, mean age, 65 years [standard deviation 11.1]). A final diagnosis of a malignant disorder was made in 151 patients (79%). Of these, EBUS-TBNA alone provided the diagnosis in 135 patients. The majority of the remaining 56 patients had reactive changes (n = 32). Nineteen patients, either because they did not respond to appropriate treatment or based on clinical indication, underwent a different procedure resulting in an additional diagnosis of malignancy in 16 patients, tuberculosis in one and indeterminate in two. The diagnostic yield of EBUS for malignant disorders was 70.7% (95% confidence interval (CI), 0.86, 0. 77). The overall ability of EBUS to achieve a definitive diagnosis (benign plus malignant) was 90.1% (95% CI, 0.85, 0. 94). Logistic regression and stepwise regression analysis revealed that older age, greater lymph node size, and the presence of intraprocedure complications significantly influenced EBUS yield for malignancy.Conclusion: EBUS-TBNA has a high diagnostic yield for mediastinal lesions, both benign and malignant. The yield depends on both lesion- and patient-related factors.
机译:背景:分析3年内经支气管内超声(EBUS)引导的经支气管针吸(TBNA)的诊断率。方法:招募接受EBUS评估肺/纵隔病变的连续患者。结果:100研究对象为91名患者(54%男性,平均年龄65岁[标准差11.1])。 151名患者(79%)做出了恶性疾病的最终诊断。其中,仅EBUS-TBNA即可诊断135例患者。其余56例患者中大多数有反应性改变(n = 32)。 19名患者(由于未对适当治疗做出反应或基于临床适应症)进行了不同的治疗,导致16例患者进一步诊断为恶性肿瘤,其中1例为结核病,2例不确定。 EBUS对恶性疾病的诊断率为70.7%(95%置信区间(CI),0.86、0。77)。 EBUS实现明确诊断(良性与恶性)的总体能力为90.1%(95%CI,0.85,0。94)。 Logistic回归和逐步回归分析显示,年龄大,淋巴结肿大和术中并发症的存在显着影响了EBUS的恶性程度。结论:EBUS-TBNA对良性和恶性纵隔病变的诊断率很高。产量取决于病变和患者相关因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号